Relapsed/Refractory Mantle Cell Lymphoma: Beyond BTK Inhibitors

Mantle cell lymphoma (MCL) is a rare mature B-cell non-Hodgkin lymphoma (B-NHL) with historically poor outcomes. Virtually all patients will eventually experience refractory or relapsed (R/R) disease, with a virulent course of resistance and serial relapses, making treatment challenging. The availab...

Full description

Bibliographic Details
Main Authors: Madelyn Burkart, Reem Karmali
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Journal of Personalized Medicine
Subjects:
Online Access:https://www.mdpi.com/2075-4426/12/3/376